Skip to main content

Schonfeld Strategic Advisors LLC

Source: SEC Form 13F · as of Mar 2026

Schonfeld Strategic Advisors LLC holds 91 biotech & pharma companies tracked by BioSniper, totaling $232.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

91

Total value held

$232.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for AMICUS THERAPEUTICS, INC. (FOLD)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
FOLDAMICUS THERAPEUTICS, INC.1,757,899$25.4M
ALNYALNYLAM PHARMACEUTICALS, INC.71,767$23.7M
PTCTPTC THERAPEUTICS, INC.318,405$21.7M
ANIPANI PHARMACEUTICALS INC185,629$14.3M
JAZZJazz Pharmaceuticals plc62,142$11.7M
INSMINSMED Inc56,056$9.2M
TERNTerns Pharmaceuticals, Inc.165,725$8.7M
ELVNEnliven Therapeutics, Inc.218,867$8.6M
GPCRStructure Therapeutics Inc.165,426$8.0M
CNTACentessa Pharmaceuticals plc171,933$6.8M
AGIOAGIOS PHARMACEUTICALS, INC.200,061$6.8M
CYTKCYTOKINETICS INC101,565$6.7M
KALVKalVista Pharmaceuticals, Inc.315,537$6.4M
DNTHDianthus Therapeutics, Inc. /DE/73,468$6.2M
CMPXCompass Therapeutics, Inc.1,076,004$5.7M
APLSApellis Pharmaceuticals, Inc.123,824$5.0M
COGTCogent Biosciences, Inc.112,463$4.3M
RCUSArcus Biosciences, Inc.193,561$4.2M
ADPTAdaptive Biotechnologies Corp262,199$3.6M
ASMBASSEMBLY BIOSCIENCES, INC.120,500$3.3M
ADMAADMA BIOLOGICS, INC.330,148$3.0M
TNGXTango Therapeutics, Inc.120,689$2.5M
SUPNSUPERNUS PHARMACEUTICALS, INC.48,765$2.5M
RNAAtrium Therapeutics Inc.162,759$2.2M
KNSAKiniksa Pharmaceuticals International, plc43,599$2.1M
APGEApogee Therapeutics, Inc.23,088$1.9M
HRMYHarmony Biosciences Holdings, Inc.68,116$1.9M
XERSXeris Biopharma Holdings, Inc.296,431$1.7M
STOKStoke Therapeutics, Inc.49,302$1.6M
ABVXAbivax SA14,313$1.6M
ROIVRoivant Sciences Ltd.53,888$1.5M
UPBUpstream Bio, Inc.161,349$1.5M
ABSIAbsci Corporation332,263$997K
FDMT4D Molecular Therapeutics, Inc.101,110$941K
KODKodiak Sciences Inc.22,152$844K
IMVTImmunovant, Inc.33,553$833K
QUREuniQure N.V.48,824$798K
MRNAModerna, Inc.15,691$797K
LQDALiquidia Corp20,551$776K
ANNXAnnexon, Inc.123,282$683K
ARWRARROWHEAD PHARMACEUTICALS, INC.10,002$627K
NKTRNEKTAR THERAPEUTICS8,063$580K
CMPSCOMPASS Pathways plc102,828$569K
MLTXMoonLake Immunotherapeutics28,682$535K
PGENPRECIGEN, INC.135,753$525K
ABCLAbCellera Biologics Inc.141,295$493K
OVIDOvid Therapeutics Inc.212,211$471K
SMMTSummit Therapeutics Inc.22,505$427K
GMABGenmab A/S13,467$361K
LENZLENZ Therapeutics, Inc.39,285$359K
ZBIOZenas BioPharma, Inc.17,638$345K
TLXTelix Pharmaceuticals Limited34,873$334K
CTMXCytomX Therapeutics, Inc.67,732$318K
OGNOrganon & Co.52,525$315K
NUVLNuvalent, Inc.2,945$302K
DMRADamora Therapeutics, Inc.10,824$280K
ATAIAtai Beckley N.V.77,611$275K
SPRYARS Pharmaceuticals, Inc.33,032$265K
RXRXRECURSION PHARMACEUTICALS, INC.84,556$260K
MANEVeradermics Incorporated3,900$246K
ARDXARDELYX, INC.39,299$235K
SLDBSolid Biosciences Inc.30,493$220K
VCELVericel Corp6,718$216K
AQSTAquestive Therapeutics, Inc.51,817$215K
DFTXDefinium Therapeutics Inc.10,412$197K
OCGNOcugen, Inc.108,665$197K
LRMRLarimar Therapeutics, Inc.38,090$171K
RLMDRELMADA THERAPEUTICS, INC.23,247$162K
SIGASIGA TECHNOLOGIES INC25,644$137K
PRTAPROTHENA CORP PUBLIC LTD CO12,399$121K
RGNXREGENXBIO Inc.14,151$119K
LXRXLEXICON PHARMACEUTICALS, INC.75,110$117K
EDSAEdesa Biotech, Inc.19,650$103K
ZURAZura Bio Ltd16,146$96K
ELABPMGC Holdings Inc.14,800$89K
NBPNovaBridge Biosciences35,414$87K
XFORX4 Pharmaceuticals, Inc19,514$81K
LCTXLineage Cell Therapeutics, Inc.48,017$76K
IVVDInvivyd, Inc.52,531$68K
SVRASavara Inc11,549$63K
CCCCC4 Therapeutics, Inc.23,944$63K
PROKPROKIDNEY CORP.32,845$59K
MNOVMEDICINOVA INC36,376$50K
ZNTLZentalis Pharmaceuticals, Inc.20,600$48K
SPROSpero Therapeutics, Inc.20,314$48K
BDTXBlack Diamond Therapeutics, Inc.18,774$40K
GERNGERON CORP24,102$36K
IMUXIMMUNIC, INC.28,300$31K
PMCBPharmaCyte Biotech, Inc.27,009$18K
VTGNVistagen Therapeutics, Inc.26,589$15K
CGTXCOGNITION THERAPEUTICS INC10,000$8K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.